116 related articles for article (PubMed ID: 34310951)
1. CLEC12B Decreases Melanoma Proliferation by Repressing Signal Transducer and Activator of Transcription 3.
Montaudié H; Sormani L; Dadone-Montaudié B; Heim M; Cardot-Leccia N; Tulic MK; Beranger G; Gay AS; Debayle D; Cheli Y; Raymond JH; Sohier P; Petit V; Rocchi S; Gesbert F; Larue L; Passeron T
J Invest Dermatol; 2022 Feb; 142(2):425-434. PubMed ID: 34310951
[TBL] [Abstract][Full Text] [Related]
2. CLEC12B suppresses lung cancer progression by inducing SHP-1 expression and inactivating the PI3K/AKT signaling pathway.
Chi D; Wang D; Zhang M; Ma H; Chen F; Sun Y
Exp Cell Res; 2021 Dec; 409(2):112914. PubMed ID: 34780782
[TBL] [Abstract][Full Text] [Related]
3. CLEC12B Is a Melanocytic Gene Regulating the Color of the Skin.
Sormani L; Montaudie H; Blot L; Heim M; Cardot Leccia N; Mhaidly R; Verhoeyen E; Regazzetti C; Nottet N; Cheli Y; De Donatis GM; Dabert Gay AS; Debayle D; Taquin Martin H; Gesbert F; Rocchi S; Tulic MK; Passeron T
J Invest Dermatol; 2022 Jul; 142(7):1858-1868.e8. PubMed ID: 34896119
[TBL] [Abstract][Full Text] [Related]
4. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
Guo H; Cheng Y; Martinka M; McElwee K
Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
[TBL] [Abstract][Full Text] [Related]
5. Identification of CLEC12B, an inhibitory receptor on myeloid cells.
Hoffmann SC; Schellack C; Textor S; Konold S; Schmitz D; Cerwenka A; Pflanz S; Watzl C
J Biol Chem; 2007 Aug; 282(31):22370-5. PubMed ID: 17562706
[TBL] [Abstract][Full Text] [Related]
6. BET inhibitor suppresses melanoma progression
Deng G; Zeng F; Su J; Zhao S; Hu R; Zhu W; Hu S; Chen X; Yin M
Theranostics; 2020; 10(25):11428-11443. PubMed ID: 33052224
[No Abstract] [Full Text] [Related]
7. Selective expression of a C-type lectin receptor, Clec12b, on skin mast cells.
Iijima A; Kanemaru K; Wang Y; Nabekura T; Nakamura Y; Fujisawa Y; Mori D; Ohmuraya M; Yamasaki S; Tahara-Hanaoka S; Shibuya A
Biochem Biophys Res Commun; 2021 Jul; 561():101-105. PubMed ID: 34020140
[TBL] [Abstract][Full Text] [Related]
8. Ethacrynic acid inhibits STAT3 activity through the modulation of SHP2 and PTP1B tyrosine phosphatases in DU145 prostate carcinoma cells.
Lee YJ; Song H; Yoon YJ; Park SJ; Kim SY; Cho Han D; Kwon BM
Biochem Pharmacol; 2020 May; 175():113920. PubMed ID: 32201212
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
Wu ZS; Cheng XW; Wang XN; Song NJ
Melanoma Res; 2011 Dec; 21(6):483-90. PubMed ID: 21876460
[TBL] [Abstract][Full Text] [Related]
10. Targeting signal-transducer-and-activator-of-transcription 3 sensitizes human cutaneous melanoma cells to BRAF inhibitor.
Wang X; Qu H; Dong Y; Wang G; Zhen Y; Zhang L
Cancer Biomark; 2018; 23(1):67-77. PubMed ID: 30010109
[TBL] [Abstract][Full Text] [Related]
11. Down-Regulation of SOX2 Underlies the Inhibitory Effects of the Triphenylmethane Gentian Violet on Melanoma Cell Self-Renewal and Survival.
Pietrobono S; Morandi A; Gagliardi S; Gerlini G; Borgognoni L; Chiarugi P; Arbiser JL; Stecca B
J Invest Dermatol; 2016 Oct; 136(10):2059-2069. PubMed ID: 27373978
[TBL] [Abstract][Full Text] [Related]
12. Shp2 Inhibits Proliferation of Esophageal Squamous Cell Cancer via Dephosphorylation of Stat3.
Qi C; Han T; Tang H; Huang K; Min J; Li J; Ding X; Xu Z
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085101
[TBL] [Abstract][Full Text] [Related]
13. STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma.
Momtaz S; Niaz K; Maqbool F; Abdollahi M; Rastrelli L; Nabavi SM
Biofactors; 2017 May; 43(3):347-370. PubMed ID: 27896891
[TBL] [Abstract][Full Text] [Related]
14. STAT3-induced upregulation of lncRNA SNHG17 predicts a poor prognosis of melanoma and promotes cell proliferation and metastasis through regulating PI3K-AKT pathway.
Gao H; Liu R; Sun X
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8000-8010. PubMed ID: 31599425
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-22 targets FMNL2 to inhibit melanoma progression via the regulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
Shi L; Huo JW; Chen SS; Xue JX; Gao WY; Li XY; Song YH; Xu HT; Zhu XW; Chen K
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5332-5342. PubMed ID: 31298385
[TBL] [Abstract][Full Text] [Related]
16. Kynurenine 3-monooxygenase (KMO), and signal transducer and activator of transcription 3 (STAT3) expression is involved in tumour proliferation and predicts poor survival in canine melanoma.
Liu IL; Chung TF; Huang WH; Hsu CH; Liu CC; Chiu YH; Huang KC; Liao AT; Lin CS
Vet Comp Oncol; 2021 Mar; 19(1):79-91. PubMed ID: 32720434
[TBL] [Abstract][Full Text] [Related]
17. RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb.
Wang J; Hua W; Huang SK; Fan K; Takeshima L; Mao Y; Hoon DS
Oncotarget; 2015 Oct; 6(30):30165-77. PubMed ID: 26334503
[TBL] [Abstract][Full Text] [Related]
18. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
[TBL] [Abstract][Full Text] [Related]
19. Verbascoside Inhibits Glioblastoma Cell Proliferation, Migration and Invasion While Promoting Apoptosis Through Upregulation of Protein Tyrosine Phosphatase SHP-1 and Inhibition of STAT3 Phosphorylation.
Jia WQ; Wang ZT; Zou MM; Lin JH; Li YH; Zhang L; Xu RX
Cell Physiol Biochem; 2018; 47(5):1871-1882. PubMed ID: 29961065
[TBL] [Abstract][Full Text] [Related]
20. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ
Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
